Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Alphatec Holdings Inc. (ATEC:NASDAQ), powered by AI.
Alphatec Holdings Inc. is currently trading at $6.99. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Alphatec Holdings Inc. on Alpha Lenz.
Alphatec Holdings Inc.'s P/E ratio is -6.2.
“Alphatec Holdings Inc. trades at a P/E of -6.2 (undervalued) with modest ROE of -507.1%. 3Y revenue CAGR of 36.0% highlights clear growth momentum.”
Ask for details →Alphatec Holdings Inc. is a medical technology company that specializes in the design, development, and commercialization of innovative solutions for spinal disorder treatment. The company's primary function is to provide physicians with advanced surgical tools and systems aimed at improving outcomes for patients requiring spinal surgeries. Significant for its focus on minimally invasive surgery, Alphatec Holdings Inc. develops a comprehensive suite of products, including implants and surgical instruments tailored for various spinal pathologies. The healthcare sector, particularly the orthopedic and neurosurgical fields, heavily relies on the innovative approaches brought forth by Alphatec. Within the medical technology market, the company plays a crucial role by continually setting benchmarks for enhanced surgical performance and patient care, contributing to the ongoing evolution of spinal health solutions and maintaining its significance among healthcare providers worldwide.
“Alphatec Holdings Inc. trades at a P/E of -6.2 (undervalued) with modest ROE of -507.1%. 3Y revenue CAGR of 36.0% highlights clear growth momentum.”
Ask for details →Alphatec Holdings Inc. (ticker: ATEC) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 867 employees. Market cap is $999M.
The current price is $6.99 with a P/E ratio of -6.16x and P/B of -70.52x.
ROE is -507.05% and operating margin is -20.10%. Annual revenue is $612M.